The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. .
Share this article
Share this article
Grant to support MIGAL s groundbreaking research into treatments for Colitis and Crohn s Disease led by Dr. Dorit Avni
QIRYAT SHMONA, Israel, Feb. 1, 2021 /PRNewswire/ The MIGAL Galilee Research Institute (MIGAL) a regional mega-R&D center supported by Israel s Ministry of Science and Technology, today announced that ALGAE4IBD, a project initiated, led and coordinated by Dr. Dorit Avni, the group leader of MIGAL s Bioactive Metabolites and Immune Modulation Laboratory, has been awarded a prestigious EU (European Union) HORIZON 2020 R&D grant in the amount of EUR 7.5 million.
The aim of the grant is to promote a breakthrough in the development of natural ingredients from algae, leveraging their unique capabilities to develop novel treatments for inflammatory diseases with no existing cures, such as Inflammatory Bowel Disease (IBD); Colitis and Crohn s Disease.